Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 1

Status

Completed 6Unknown 1Terminated 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Dermatologic 6Thoracic 1Genitourinary 1Endocrine 1

Conditions

Breast Neoplasms 52Carcinoma, Renal Cell 47Neoplasm Metastasis 24Neoplasms 18Kidney Neoplasms 18Neuroendocrine Tumors 17Carcinoma, Non-Small-Cell Lung 13Tuberous Sclerosis 12Stomach Neoplasms 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 11Recurrence 10Prostatic Neoplasms 10Lymphoma 10Hodgkin Disease 10Glioblastoma 10Colorectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Brain Neoplasms 9Lymphoma, Follicular 8Lung Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Carcinoma 8Waldenstrom Macroglobulinemia 7Triple Negative Breast Neoplasms 7Sarcoma 7Multiple Myeloma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Central Nervous System Neoplasms 7

Interventions

Ipilimumab 114pembrolizumab 95Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Melanoma × Everolimus × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT00591734 2021-11-24

RAD001 Plus Bevacizumab in Metastatic Melanoma

SCRI Development Innovations, LLC

Phase 2 Completed
57 enrolled 7 charts
Dermatologic

Melanoma

NCT00521001 2017-08-14

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Alliance for Clinical Trials in Oncology

Phase 2 Completed
49 enrolled 8 charts
Dermatologic

Melanoma

NCT00976573 2017-04-04

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
149 enrolled 9 charts
Dermatologic

Melanoma

NCT00098553 2016-07-06

Everolimus in Treating Patients With Stage IV Melanoma

Alliance for Clinical Trials in Oncology

Phase 2 Completed
53 enrolled
Dermatologic

Melanoma

NCT01014351 2014-03-26

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

SCRI Development Innovations, LLC

Phase 2 Completed
70 enrolled 8 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡